Waters Corporation

Equities

WAT

US9418481035

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 10:43:35 16/07/2024 pm IST			5-day change	1st Jan Change
312.5 ^USD	+3.17%		+10.50%	-5.03%

15/07	TD Cowen Adjusts Price Target on Waters to $325 From $358, Maintains Hold Rating	MT
02/07	Evercore ISI Adjusts Price Target on Waters to $300 From $320, Maintains In-Line Rating	MT

Waters Corporation announces an Equity Buyback for $4,000 million worth of its shares.

January 23, 2019 at 05:31 pm IST

Waters Corporation (NYSE:WAT) announces a share repurchase program. Under the program, the company will repurchase up to $4,000 million worth of its common shares. The program will be valid for a period of 2 years.

Latest news about Waters Corporation

TD Cowen Adjusts Price Target on Waters to $325 From $358, Maintains Hold Rating	15/07	MT
Evercore ISI Adjusts Price Target on Waters to $300 From $320, Maintains In-Line Rating	02/07	MT
Waters Corporation(NYSE:WAT) added to Russell Midcap Value Index	01/07	CI
Waters Corporation(NYSE:WAT) added to Russell 3000 Value Index	01/07	CI
Waters Corporation(NYSE:WAT) added to Russell 1000 Value-Defensive Index	01/07	CI
Waters Corporation(NYSE:WAT) added to Russell 1000 Value Index	01/07	CI
Waters Corporation(NYSE:WAT) added to Russell 3000E Value Index	01/07	CI
Barclays Adjusts Price Target on Waters to $275 From $295	27/06	MT
Transcript : Waters Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 09:30 AM	05/06
Waters Insider Bought Shares Worth $332,900, According to a Recent SEC Filing	29/05	MT
Deutsche Bank Adjusts Waters Price Target to $330 From $304	22/05	MT
Waters Corp Insider Sold Shares Worth $1,446,560, According to a Recent SEC Filing	16/05	MT
Bernstein Adjusts Price Target on Waters to $307 From $304	08/05	MT
JPMorgan Adjusts Price Target on Waters to $315 From $300	08/05	MT
TD Cowen Adjusts Price Target on Waters to $358 From $350	08/05	MT
Stifel Nicolaus Adjusts Waters Price Target to $332 From $330	08/05	MT
Baird Adjusts Waters Price Target to $312 From $319	08/05	MT
Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip	08/05	RE
Barclays Lowers Waters' Price Target to $295 From $300	08/05	MT
Evercore IS Adjusts Waters' Price Target to $320 From $340, Keeps In Line Rating	07/05	MT
Waters Seeks M&A Opportunities	07/05	CI
Transcript : Waters Corporation, Q1 2024 Earnings Call, May 07, 2024	07/05
Waters' Q1 Non-GAAP Earnings, Net Sales Decline; Q2 Outlook Issued	07/05	MT
Earnings Flash (WAT) WATERS CORPORATION Reports Q1 Revenue $636.8M	07/05	MT
Earnings Flash (WAT) WATERS CORPORATION Reports Q1 Adjusted EPS $2.21	07/05	MT

Chart Waters Corporation

Duration

Period

More charts

Company Profile

Waters Corporation specializes in the conception, the manufacturing and the marketing of analytical instruments. Net sales break down by activity as follows: - sale of instruments and analytical systems (63.6%): chromatographic analysis instruments (59.5% of net sales; instruments high performance liquid chromatography and mass spectrometry), chemistry consumables (28.9%; including columns chemical separation) and thermal analysis, rheometry and calorimetry instruments (11.6%) ; - services (36.7%): support services, training, etc. Net sales are distributed by market between pharmaceutical (58.6%), industrial (29.9%), academic institutions and governmental agencies (11.4%). Net sales are distributed geographically as follows: the United States (28.7%), Americas (5.1%), China (17.1%), Japan (7.6%), Asia (13.3%) and Europe (28.2%).

Sector

Advanced Medical Equipment & Technology

Calendar

31/07/2024 - Q2 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Waters Corporation

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

302.9 USD

Average target price

320.8 USD

Spread / Average Target

+5.91%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
WATERS CORPORATION	-5.03%	17.97B
THERMO FISHER SCIENTIFIC	+4.30%	208B
DANAHER CORPORATION	+8.35%	182B
INTUITIVE SURGICAL, INC.	+29.22%	155B
BOSTON SCIENTIFIC CORPORATION	+35.00%	115B
SIEMENS HEALTHINEERS AG	+2.55%	66.52B
EDWARDS LIFESCIENCES CORPORATION	+15.02%	53.93B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-6.47%	46.26B
AGILENT TECHNOLOGIES, INC.	-2.96%	38.22B
GE HEALTHCARE TECHNOLOGIES INC.	+6.42%	36.6B

Other Advanced Medical Equipment & Technology